NAPSA and lung carcinoma: On a set of lung cancer samples (ADC, SCC and SCLC and paratumor), we demonstrated .the ability of RPPA to classify patients using conventional pathological markers (Napsin A, cytokeratin7, TTF1, p40/p63 and EGFR)..